Abstract
Patients suffering from ischemic stroke carry an enhanced risk of developing secondary epilepsy. We sought to clarify whether thrombolytic treatment with recombinant tissue plasminogen activator (t-PA) is independently associated with post-stroke epilepsy (PSE). In this observational study, data from 302 stroke patients treated at a single academic neurological department were analyzed retrospectively. Median follow-up was 42 months (maximum 80). Variables included presence of comorbidity, stroke severity, neurological presentation, complications, infarct characteristics, and treatment with t-PA. After univariate analyses, a multivariate analysis was performed to create a model of factors that were significantly associated with PSE, including treatment with t-PA. 13.9 % of patients developed PSE during follow-up. Multivariate analysis identified 5 independent factors for PSE: low Barthel Index at discharge; hemianopia; infection acquired during the hospital stay; involvement of the temporal lobe; involvement of the perirolandic cortex. While the incidence of PSE was higher in patients treated with t-PA (20.6 vs. 10.7 %, univariate analysis; p = 0.020), the effect was lost after adjusting for several factors associated with t-PA treatment [odds ratio for PSE after treatment with t-PA 1.3 (95 % CI 0.6–2.9), p = 0.489]. This study failed to identify treatment with t-PA as an independent risk factor for PSE.
Similar content being viewed by others
References
Sander JW, Hart YM, Johnson AL et al (1990) National General Practice Study of Epilepsy:newly diagnosed epileptic seizures in a general population. Lancet 336(8726):1267–1271
Roberts MA, Godfrey JW, Caird FI (1982) Epileptic seizures in the elderly: I. aetiology and type of seizure. Age Ageing 11(1):24–28
So EL, Annegers JF, Hauser WA et al (1996) Population-based study of seizure disorders after cerebral infarction. Neurology 46(2):350–355
Bladin CF, Alexandrov AV, Bellavance A et al (2000) Seizures after stroke. A prospective multicenter study. Arch Neurol 57(11):1617–1622
Camilo O, Goldstein LB (2004) Seizures and epilepsy after ischemic stroke. Stroke 35(7):1769–1775. doi:10.1161/01.STR.0000130989.17100.96
Myint PK, Staufenberg EFA, Sabanathan K (2006) Post-stroke seizure and post-stroke epilepsy. Postgrad Med J 82(971):568–572. doi:10.1136/pgmj.2005.041426
Menon B, Shorvon SD (2009) Ischaemic stroke in adults and epilepsy. Epilepsy Res 87(1):1–11. doi:10.1016/j.eplepsyres.2009.08.007
Arntz RM, Maaijwee NAM, Rutten-Jacobs LCA et al (2013) Epilepsy after TIA or stroke in young patients impairs long-term functional outcome: the FUTURE Study. Neurology 81(22):1907–1913. doi:10.1212/01.wnl.0000436619.25532.f3
Hacke W, Kaste M, Bluhmki E et al (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359(13):1317–1329. doi:10.1056/NEJMoa0804656
Saver JL, Fonarow GC, Smith EE et al (2013) Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA 309(23):2480–2488. doi:10.1001/jama.2013.6959
Stolz E, Hamann GF, Kaps M et al (2011) Regional differences in acute stroke admission and thrombolysis rates in the German federal state of Hesse. Dtsch Arztebl Int 108(36):607–611. doi:10.3238/arztebl.2011.0607
Goto H, Fujisawa H, Oka F et al (2007) Neurotoxic effects of exogenous recombinant tissue-type plasminogen activator on the normal rat brain. J Neurotrauma 24(4):745–752. doi:10.1089/neu.2006.0183
Lemarchant S, Docagne F, Emery E et al (2012) tPA in the injured central nervous system:different scenarios starring the same actor? Neuropharmacology 62(2):749–756. doi:10.1016/j.neuropharm.2011.10.020
Harston GWJ, Sutherland BA, Kennedy J et al (2010) The contribution of l-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia:a review of rtPA neurotoxicity. J Cereb Blood Flow Metab 30(11):1804–1816. doi:10.1038/jcbfm.2010.149
Samson AL, Medcalf RL (2006) Tissue-type plasminogen activator:a multifaceted modulator of neurotransmission and synaptic plasticity. Neuron 50(5):673–678. doi:10.1016/j.neuron.2006.04.013
de Reuck J, van Maele G (2010) Acute ischemic stroke treatment and the occurrence of seizures. Clin Neurol Neurosurg 112(4):328–331. doi:10.1016/j.clineuro.2010.01.004
Roivainen R, Haapaniemi E, Putaala J et al (2013) Young adult ischaemic stroke related acute symptomatic and late seizures:risk factors. Eur J Neurol 20(9):1247–1255. doi:10.1111/ene.12157
Alvarez V, Rossetti AO, Papavasileiou V et al (2013) Acute seizures in acute ischemic stroke:does thrombolysis have a role to play? J Neurol 260(1):55–61. doi:10.1007/s00415-012-6583-6
Creutzfeldt CJ, Tirschwell DL, Kim LJ et al (2013) Seizures after decompressive hemicraniectomy for ischaemic stroke. J Neurol Neurosurg Psychiatr. doi:10.1136/jnnp-2013-305678
Tan M, Ng A, Pandher PS et al (2012) Tissue plasminogen activator does not alter development of acquired epilepsy. Epilepsia 53(11):1998–2004. doi:10.1111/j.1528-1167.2012.03635.x
Rodan LH, Aviv RI, Sahlas DJ et al (2006) Seizures during stroke thrombolysis heralding dramatic neurologic recovery. Neurology 67(11):2048–2049. doi:10.1212/01.wnl.0000247231.25231.2e
Stefan H (2011) Epilepsy in the elderly:facts and challenges. Acta Neurol Scand 124(4):223–237. doi:10.1111/j.1600-0404.2010.01464.x
Fisher RS, van Emde Boas W, Blume W et al (2005) Epileptic seizures and epilepsy:definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 46(4):470–472. doi:10.1111/j.0013-9580.2005.66104.x
Hamidou B, Aboa-Eboulé C, Durier J et al (2013) Prognostic value of early epileptic seizures on mortality and functional disability in acute stroke:the Dijon Stroke Registry (1985–2010). J Neurol 260(4):1043–1051. doi:10.1007/s00415-012-6756-3
Sacco RL, Kasner SE, Broderick JP et al (2013) An updated definition of stroke for the 21st century:a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44(7):2064–2089. doi:10.1161/STR.0b013e318296aeca
Gupta SR, Naheedy MH, Elias D et al (1988) Postinfarction seizures. A clinical study. Stroke 19(12):1477–1481
Kretschmann H, Weinrich W (2004) Cranial neuroimaging and clinical neuroanatomy. Atlas of MR imaging and computed tomography, 3rd edn. Georg Thieme Verlag; Thieme Medical Publishers, Stuttgart, New York
Pellkofer T (2004) Progressive lakunäre Schlaganfälle: Pathophysiologie, Verlauf und Prognose. Dissertation, Ludwig-Maximilians-Universität
von Kummer R, Allen KL, Holle R et al (1997) Acute stroke:usefulness of early CT findings before thrombolytic therapy. Radiology 205(2):327–333. doi:10.1148/radiology.205.2.9356611
Naess H, Nyland HI, Thomassen L et al (2004) Long-term outcome of cerebral infarction in young adults. Acta Neurol Scand 110(2):107–112. doi:10.1111/j.1600-0404.2004.00273.x
de Reuck J, Goethals M, Vonck K et al (2005) Clinical predictors of late-onset seizures and epilepsy in patients with cerebrovascular disease. Eur Neurol 54(2):68–72. doi:10.1159/000087715
Fukujima MM, Cardeal JO (1997) Características das crises epilépticas após acidente vascular cerebral isquêmico (Characteristics of epileptic seizures after ischemic stroke). Arq Neuropsiquiatr 55(4):741–748
Lossius MI, Rønning OM, Slapø GD et al (2005) Poststroke epilepsy:occurrence and predictors–a long-term prospective controlled study (Akershus Stroke Study). Epilepsia 46(8):1246–1251. doi:10.1111/j.1528-1167.2005.57904.x
Strzelczyk A, Haag A, Raupach H et al (2010) Prospective evaluation of a post-stroke epilepsy risk scale. J Neurol 257(8):1322–1326. doi:10.1007/s00415-010-5520-9
Boovalingam P, Witherall R, Ho CL et al (2012) Post-stroke epilepsy. GM (Geriatric Medcine)
Szilágyi G, Vas A, Kerényi L et al (2012) Correlation between crossed cerebellar diaschisis and clinical neurological scales. Acta Neurol Scand 125(6):373–381. doi:10.1111/j.1600-0404.2011.01576.x
Infeld B, Davis SM, Lichtenstein M et al (1995) Crossed Cerebellar Diaschisis and Brain Recovery After Stroke. Stroke 26(1):90–95. doi:10.1161/01.STR.26.1.90
Ferro JM, Pinto F (2004) Poststroke epilepsy:epidemiology, pathophysiology and management. Epidemiology, Pathophysiology and Management. Drugs Aging 21(10):639–653
Graham NSN, Crichton S, Koutroumanidis M et al (2013) Incidence and associations of poststroke epilepsy:the prospective South London Stroke Register. Stroke 44(3):605–611. doi:10.1161/STROKEAHA.111.000220
Heuts-van Raak L, Lodder J, Kessels F (1996) Late seizures following a first symptomatic brain infarct are related to large infarcts involving the posterior area around the lateral sulcus. Seizure 5(3):185–194
Heuts-Van Raak EP, Boellaard A, de Krom MC et al (1993) Supratentorial brain infarcts in adult-onset seizures; the Maastricht Epilepsy Case Register. Seizure 2(3):221–227
Arboix A, Comes E, Massons J et al (1996) Relevance of early seizures for in-hospital mortality in acute cerebrovascular disease. Neurology 47(6):1429–1435
Pezzini A, Grassi M, Del Zotto E et al (2013) Complications of acute stroke and the occurrence of early seizures. Cerebrovasc. Dis. 35(5):444–450. doi:10.1159/000348704
Huang C, Saposnik G, Fang J et al (2014) Influence of seizures on stroke outcomes:a large multicenter study. Neurology 82(9):768–776. doi:10.1212/WNL.0000000000000166
Kuntz M, Mysiorek C, Pétrault O et al (2014) Transient oxygen-glucose deprivation sensitizes brain capillary endothelial cells to rtPA at 4 h of reoxygenation. Microvasc Res 91:44–57. doi:10.1016/j.mvr.2013.12.002
An J, Haile WB, Wu F et al (2014) Tissue-type plasminogen activator mediates neuroglial coupling in the central nervous system. Neuroscience 257:41–48. doi:10.1016/j.neuroscience.2013.10.060
Kelly MA, Shuaib A, Todd KG (2006) Matrix metalloproteinase activation and blood-brain barrier breakdown following thrombolysis. Exp Neurol 200(1):38–49. doi:10.1016/j.expneurol.2006.01.032
Adibhatla RM, Hatcher JF (2008) Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke:therapeutic strategies. CNS Neurol Disord: Drug Targets 7(3):243–253
Hobohm C, Günther A, Grosche J et al (2005) Decomposition and long-lasting downregulation of extracellular matrix in perineuronal nets induced by focal cerebral ischemia in rats. J Neurosci Res 80(4):539–548. doi:10.1002/jnr.20459
Liu D, Cheng T, Guo H et al (2004) Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C. Nat Med 10(12):1379–1383. doi:10.1038/nm1122
Su EJ, Fredriksson L, Geyer M et al (2008) Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat Med 14(7):731–737. doi:10.1038/nm1787
Jin R, Yang G, Li G (2010) Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke:critical role of matrix metalloproteinases and tissue-type plasminogen activator. Neurobiol Dis 38(3):376–385. doi:10.1016/j.nbd.2010.03.008
Parathath SR, Parathath S, Tsirka SE (2006) Nitric oxide mediates neurodegeneration and breakdown of the blood-brain barrier in tPA-dependent excitotoxic injury in mice. J Cell Sci 119(Pt 2):339–349. doi:10.1242/jcs.02734
Lee H, Hwang I, Im H et al (2007) Non-proteolytic neurotrophic effects of tissue plasminogen activator on cultured mouse cerebrocortical neurons. J Neurochem 101(5):1236–1247. doi:10.1111/j.1471-4159.2007.04417.x
Hauser WA, Annegers JF, Kurland LT (1993) Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota:1935-1984. Epilepsia 34(3):453–468
Conrad J, Pawlowski M, Dogan M et al (2013) Seizures after cerebrovascular events:risk factors and clinical features. Seizure 22(4):275–282. doi:10.1016/j.seizure.2013.01.014
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors disclose any conflict of interest.
Rights and permissions
About this article
Cite this article
Keller, L., Hobohm, C., Zeynalova, S. et al. Does treatment with t-PA increase the risk of developing epilepsy after stroke?. J Neurol 262, 2364–2372 (2015). https://doi.org/10.1007/s00415-015-7850-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-015-7850-0